Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

51.89
Delayed Data
As of Dec 09
 +0.21 / +0.41%
Today’s Change
38.26
Today|||52-Week Range
53.14
+8.28%
Year-to-Date
Bill Ackman Comments on Zoetis
Dec 09 / GuruFocus News - Paid Partner Content
Bill Ackman Discusses Rebounding Stocks in Pershing Square 3rd-Quarter Letter
Dec 08 / GuruFocus News - Paid Partner Content
Marshall Wace partners profit from fee bonanza
Dec 09 / FT.com - Paid Partner Content
Top Research Reports for Broadcom, PNC Financial & ConocoPhillips
Dec 01 / Zacks.com - Paid Partner Content
Bill Ackman Releases Pershing Square 3rd-Quarter Letter
Dec 08 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close51.68
Today’s open51.86
Day’s range51.60 - 52.48
Volume2,664,496
Average volume (3 months)3,578,998
Market cap$25.6B
Dividend yield0.81%
Data as of 4:01pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+9.65%
Earnings growth (next 5 years)+14.54%
Revenue growth (last year)-0.42%
P/E ratio37.3
Price/Sales5.05
Price/Book24.17

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...+0.76+1.72%
ALXNAlexion Pharmaceutic...+6.07+4.82%
MYLMylan NV+0.45+1.25%
VRTXVertex Pharmaceutica...-0.55-0.71%
Data as of 4:01pm ET, 12/09/2016

Financials

Next reporting dateFebruary 21, 2017
EPS forecast (this quarter)$0.45
Annual revenue (last year)$4.8B
Annual profit (last year)$339.0M
Net profit margin7.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
Florham Park, New Jersey

Forecasts


Search for Jobs